| Financial Year |
March 31 2023 |
| Monetary Funds |
53,814,103.91 |
| Held-for-trading Financial Assets |
43,190,636.46 |
| Notes Receivable |
4,013,119.00 |
| Accounts Receivable |
270,555,534.08 |
| Advances to Suppliers |
5,956,703.42 |
| Other Receivables |
1,403,506.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
162,257,801.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
729,014,122.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
364,705,955.87 |
| Under-construction Projects |
95,169,676.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
30,846,665.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,464,836.02 |
| Deferred Income Tax Assets |
8,714,064.73 |
| Other Non-Current Assets |
11,581,674.17 |
| Sub-Total of Non-Current Assets |
540,099,373.07 |
| Total Assets |
1,269,113,495.60 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
44,980,009.34 |
| Accounts Payable |
127,786,315.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,366,107.08 |
| Taxes Payable |
6,390,771.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
80,168.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
210,663,551.25 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,147,212.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,154,990.86 |
| Total Liabilities |
232,818,542.11 |
| Paid-In Capital(Or Share Stock) |
270,720,000.00 |
| Capital Surplus |
301,095,117.24 |
| Surplus Reserve |
101,345,557.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
363,134,278.88 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,036,294,953.49 |
| Owner's Equity（Stockholder's Equity） |
1,036,294,953.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,269,113,495.60 |
